北京大学学报(医学版) ›› 2015, Vol. 47 ›› Issue (5): 743-748. doi: 10.3969/j.issn.1671-167X.2015.05.003

• 论著 • 上一篇    下一篇

间苯三酚对大鼠肾缺血再灌注损伤的保护作用

李刚1,张洪宪1,王云鹏1,张径2,洪锴1,田晓军1△,马潞林1△   

  1. (1. 北京大学第三医院泌尿外科,北京100191; 2. 海军总医院特需医疗部,北京100048)
  • 出版日期:2015-10-18 发布日期:2015-10-18
  • 通讯作者: 田晓军,马潞林 E-mail:txjtt@sina.com, malulin@medmail.com.cn

Protective effect of phloroglucinol on renal ischemia and reperfusion injury

LI Gang1, ZHANG Hong-xian1, WANG Yun-peng1, ZHANG Jing2,HONG Kai1, TIAN Xiao-jun1△, MA Lu-lin1△   

  1. (1. Department of Urology, Peking University Third Hospital, Beijing 100191, China; 2. Special Medical Department, General Navy Hospital, Beijing 100048, China)
  • Online:2015-10-18 Published:2015-10-18
  • Contact: TIAN Xiao-jun1, MA Lu-lin1 E-mail:txjtt@sina.com, malulin@medmail.com.cn

摘要:

目的:研究间苯三酚对大鼠肾缺血再灌注损伤(ischemia reperfusion injury, IRI)的保护作用及机制。方法:将雄性Wistar大鼠48只平均分为3组(n=16):假手术组(Sham组)切除大鼠右肾后,左肾动脉进行同等分离,但不予夹闭;对照组即肾缺血再灌注组(ischemia reperfusion, I/R组),腹腔注射等量的生理盐水,15 min后切除大鼠右肾,无创动脉夹夹闭左肾动脉45 min;实验组即缺血再灌注间苯三酚预处理组(phloroglucinol,PG组),腹腔注射间苯三酚注射液(30 mg/kg),15 min后切除大鼠右肾,无创动脉夹夹闭左肾动脉45 min。每组动物再均分为两个亚组(n′=8),分别于再灌注后6和24 h将大鼠处死。处死前经下腔静脉取血,检测血清肌酐(secrum creatinine, SCr)、尿素氮(blood urine nitrogen, BUN);将肾于冠状位切成两半,一半组织制作成组织匀浆,取组织上清液检测丙二醛(malondialdehyde, MDA)、过氧化氢酶(catalase, CAT)、超氧化物歧化酶(superoxide dismutase, SOD)及谷胱甘肽过氧化物酶(glutathione peroxidase, GSH-Px);另一半组织行石蜡包埋,切片进行病理组织学观察,再灌注后24 h的大鼠肾组织行核转录因子-kapa B(nuclear factor-kapa B, NF-κB)及Caspase3免疫组织化学检测。结果:再灌注后 6 h,I/R组大鼠血清SCr和BUN分别为(103.9±10.4) μmol/L和(15.2±1.0) mmol/L,PG预处理的SCr及BUN分别为(81.8±13.4) μmol/L和(11.5±1.2) mmol/L;再灌注后24 h,I/R组大鼠血清SCr和BUN分别为(154.9±12.1) μmol/L和(28.1±1.4) mmol/L,PG预处理的SCr及BUN分别为(103.8±5.9) μmol/L和(16.0±1.0) mmol/L;PG预处理组较I/R组明显改善肾功能(P<0.05);苏木素-伊红染色病理图片可见肾小管损伤较I/R组明显减轻(P<0.05);经PG处理后大鼠肾组织内MDA含量较I/R组低(P<0.05),SOD及CAT含量较I/R组高(P<0.05),GSH-Px含量较I/R组高(P<0.05)。再灌注后24 h,经间苯三酚处理的肾组织内核因子-kapa B在细胞核内表达的水平明显降低,活化的Caspase-3亦较I/R组有所减少。结论:间苯三酚通过减轻氧化应激和炎性损伤,抑制细胞凋亡,有效改善了大鼠肾IRI。

关键词: 间苯三酚, 肾, 再灌注损伤, 氧化性应激, 细胞凋亡

Abstract:

Objective:To investigate the effect and mechanisms of Phloroglucinol (PG) on renal ischemia and reperfusion injury (IRI). Methods: Forty-eight male Wistar rats were divided into 3 groups (16 rats per group): sham operated, saline-treated I/R (I/R), and PG-treated I/R (PG). I/R model: After removing the right kidney, renal I/R injury was induced by clamping the left renal artery for 45 min followed by reperfusion. The rats were administered with PG (30 mg/kg, intraperitoneally) or saline 15 min before renal ischemia. The blood and kidneys were harvested 6 and 24 h after reperfusion. Renal function and histologic changes of serum creatinine (SCr) and blood urea nitrogen(BUN)were assessed. Malondialdehyde (MDA),catalase (CAT),superoxide dismutase (SOD), and glutathione peroxidase (GSH-Px)were measured. Nuclear factor-kapa B (NF-κB) and caspase-3 in the kidneys were also measured. Results: SCr and BUN were (103.9±10.4) μmol/L and (15.2±1.0) mmol/L in I/R group, and (81.8±13.4) μmol/L and (11.5±1.2) mmol/L in PG group 6 h after reperfusion. SCr and BUN were (154.9±12.1) μmol/L and (28.1±1.4) mmol/L in I/R group, and (103.8±5.9) μmol/L和(16.0±1.0) mmol/L in PG group 24 h after reperfusion.PG treatment significantly attenuated renal dysfunction and histologic damage caused by I/R injury(P<0.05).The I/Rinduced elevation in kidney MDA level decreased, where as reduced kidney SOD,CAT and GSH-Px were increased. What is more, the apoptotic tubular cells, the levels of active caspase-3,and active nuclear factor kappa B dramatically decreased after PG treatment. Conclusion: PG protects murine kidney I/R injury by suppres-sing oxidative stress, inflammation, and cell apoptosis.

Key words: Phloroglucinol, Kidney, Reperfusion injury, Oxidative stress, Apoptosis

中图分类号: 

  •  
[1] 丁汉东, 王琴, 廖贵益, 郝宗耀. 肾移植术后并发消化道出血的诊治[J]. 北京大学学报(医学版), 2024, 56(5): 902-907.
[2] 陈思鹭, 王海菊, 吴宇财, 李志华, 黄燕波, 何宇辉, 许洋洋, 李学松, 贯华. 成人肾积水病因分析:一项单中心横断面研究[J]. 北京大学学报(医学版), 2024, 56(5): 913-918.
[3] 王明瑞, 王起, 胡浩, 赖金惠, 唐鑫伟, 万春艳, 许克新, 徐涛. 覆膜金属输尿管支架治疗盆腔脂肪增多症所致肾积水的疗效[J]. 北京大学学报(医学版), 2024, 56(5): 919-922.
[4] 张树栋,谢睿扬. 机器人手术时代的肾癌合并腔静脉瘤栓治疗策略[J]. 北京大学学报(医学版), 2024, 56(4): 562-564.
[5] 王明瑞,刘军,熊六林,于路平,胡浩,许克新,徐涛. 经皮微通道-微电子肾镜-微超声探针碎石术治疗1.5~2.5 cm肾结石的疗效和安全性[J]. 北京大学学报(医学版), 2024, 56(4): 605-609.
[6] 郑生旗,花天池,殷桂草,张伟,姚曳,李一帆. 甘油三酯葡萄糖指数与男性肾结石风险的关联[J]. 北京大学学报(医学版), 2024, 56(4): 610-616.
[7] 陈克伟,刘茁,邓绍晖,张帆,叶剑飞,王国良,张树栋. 肾血管平滑肌脂肪瘤伴下腔静脉瘤栓的临床诊治[J]. 北京大学学报(医学版), 2024, 56(4): 617-623.
[8] 刘帅,刘磊,刘茁,张帆,马潞林,田晓军,侯小飞,王国良,赵磊,张树栋. 伴静脉癌栓的肾上腺皮质癌的临床治疗及预后[J]. 北京大学学报(医学版), 2024, 56(4): 624-630.
[9] 杨捷,冯杰莉,张树栋,马潞林,郑清. 经食管超声心动图在肾切除术联合Mayo Ⅲ~Ⅳ级静脉瘤栓取栓术不同手术方式中的临床作用[J]. 北京大学学报(医学版), 2024, 56(4): 631-635.
[10] 王滨帅,邱敏,张前进,田茂锋,刘磊,王国良,陆敏,田晓军,张树栋. 6例肾尤文肉瘤伴静脉瘤栓的诊治[J]. 北京大学学报(医学版), 2024, 56(4): 636-639.
[11] 杨文博,余磊,张维宇,徐涛,王强. 带线输尿管支架自排技术在肾移植受者中的效果及安全性[J]. 北京大学学报(医学版), 2024, 56(4): 656-660.
[12] 虞乐,邓绍晖,张帆,颜野,叶剑飞,张树栋. 具有低度恶性潜能的多房囊性肾肿瘤的临床病理特征及预后[J]. 北京大学学报(医学版), 2024, 56(4): 661-666.
[13] 舒帆,郝一昌,张展奕,邓绍晖,张洪宪,刘磊,王国良,田晓军,赵磊,马潞林,张树栋. 肾部分切除术治疗囊性肾癌的功能学和肿瘤学结果:单中心回顾性研究[J]. 北京大学学报(医学版), 2024, 56(4): 667-672.
[14] 周泽臻,邓绍晖,颜野,张帆,郝一昌,葛力源,张洪宪,王国良,张树栋. 非转移性T3a肾细胞癌患者3年肿瘤特异性生存期预测[J]. 北京大学学报(医学版), 2024, 56(4): 673-679.
[15] 乔佳佳,田聪,黄晓波,刘军. 肾结石合并系统性红斑狼疮行经皮肾镜碎石取石术的安全性和有效性评估[J]. 北京大学学报(医学版), 2024, 56(4): 745-749.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!